Melina Elpi Marmarelis, MD, MSCE

faculty photo
Associate Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania
Attending Physician , Hospital of the University of Pennsylvania
Attending Physician , Penn Presbyterian Medical Center
Medical Director of Penn Medicine Mesothelioma and Pleural Program, University of Pennsylvania
PC3I Faculty, Penn Center for Cancer Care Innovation, University of Pennsylvania
Physician Lead -Airways Research Program, University of Pennsylvania
Department: Medicine

Contact information
Perelman Center for Advanced Medicine
3400 Civic Center Blvd
10th Floor
Philadelphia, PA 19104
Education
BA (Bachelors in Biochemistry and Molecular Biology )
Dartmouth College, 2007.
MD (Medicine)
Harvard Medical School , 2013.
MSCE (Clinical Epidemiology )
University of Pennsylvania , 2019.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Lung cancer and mesothelioma.

Description of Research Expertise

Clinical trials in lung cancer in mesothelioma.

Selected Publications

Kleeman SO, Riazat-Kesh Y, Carvajal R, Marmarelis ME, Schadendorf D, Sharon E, Othus M, Robert C, Skoulidis F, Izar B, Maki RG, Janowitz T.: Cancer Chemoimmunotherapy: Time Will Tell. Cancer Immunol Res 14: 1212-1215, Aug 2026.

Barsouk AA, Yaskolko M, Sussman JH, Sun L, Singh AP, Cohen RB, Aggarwal C, Marmarelis ME, Langer CJ.: Poor Performance Status Associated With Inferior Tarlatamab Outcomes in a Large, Multi-institution Real-World Database of Patients With 2L + ES-SCLC. Clin Lung Cancer 27: 50-55, Jul 2026.

Melina E. Marmarelis, Adrienne M. Gilligan, Tomoko Sugihara, Tyler Marquart, Sam Whipple, Yufei Wang, Taylor J Allen-Coyle, Naleen Raj Bhandari, Charu Aggarwal: The Waiting Game: How NGS and Guideline-Concordant-Care Timing Shape Survival in Advanced NSCLC. Cancers 18(14): 2287, July 2026.

Benjamin A. Bleiberg, Dylan G. Scholes, Lauren Reed-Guy, Devaki Dravid, Lova L. Sun, Aditi P. Singh, Roger B. Cohen, Corey J. Langer, Melina E. Marmarelis, Charu Aggarwal: The incremental value of liquid biopsy in the initial evaluation of patients with metastatic non-small cell lung cancer undergoing tissue-based molecular testing. The Journal of Liquid Biopsy 12, June 2026.

Sam O. Kleeman; Yosef Riazat-Kesh; Richard Carvajal; Melina E. Marmarelis; Dirk Schadendorf; Elad Sharon; Megan Othus; Caroline Robert; Ferdinandos Skoulidis; Benjamin Izar; Robert G. Maki; Tobias Janowitz.: Cancer chemo-immunotherapy: time will tell. Cancer Immunology Research June 2026.

Benjamin A. Bleiberg, Lauren Reed-Guy, Roger B. Cohen, Charu Aggarwal, Corey J. Langer, Aditi P. Singh, Melina E. Marmarelis: Carboplatin plus Pemetrexed versus Pemetrexed alone in Advanced Thymoma and Thymic Carcinoma: A Retrospective Cohort Study. Frontiers June 2026.

Bleiberg BA, Scholes DG, Reed-Guy L, Dravid D, Sun LL, Singh AP, Cohen RB, Langer CJ, Marmarelis ME, Aggarwal C.: Erratum to "The incremental value of liquid biopsy in the initial evaluation of patients with metastatic non-small cell lung cancer undergoing tissue-based molecular testing" [J. Liq. Biopsy 12 (2026) 100461] J Liq Biopsy 12: 100472, May 2026.

Cole Friedes, Michelle Iocolano, Nikhil Yegya-Raman, John C Kucharczuk, Taine T V Pechet, Roger B Cohen, Charu Aggarwal, Melina E Marmarelis, William P Levin, Keith A Cengel, Christine A Ciunci, Christopher D'Avella, Aditi P Singh, Christiana W Davis, Corey J Langer, Jeffrey Bradley, Steven J Feigenberg: Real World Radiographic Response Rates and Preoperative Attrition in Patients With Non-Small Cell Lung Cancer (NSCLC) Treated With Neoadjuvant Chemoimmunotherapy. American Journal of Clinical Oncology May 2026.

Teja Voruganti, Christiana Davis, Melina E. Marmarelis, Charu Aggarwal: Illusion of Comprehensive Testing in Non–Small Cell Lung Cancer: Why Coverage, Sensitivity, and Reporting Matter. JCO Oncology Practice April 2026.

Melina E. Marmarelis, Adrienne M. Gilligan, Tomoko Sugihara, Shen Zheng, Tyler Marquart, Samuel Whipple, Naleen Raj Bhandari, Charu Aggarwal: Evaluation of Guideline-Recommended Care in First-Line Treatment for Advanced/Metastatic Non-Small Cell Lung Cancer Patients who underwent Next-Generation Sequencing Testing: Results from a Real-World Study. Cancer Treatment and Research Communications April 2026.

back to top
Last updated: 09/01/2026
The Trustees of the University of Pennsylvania